MedPath

Prospective study to evaluate trained immunity in kidney transplantatio

Recruiting
Conditions
niertransplantatie
graft survival
kidney transplantation
Registration Number
NL-OMON53183
Lead Sponsor
Radboud Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

Kidney transplant recipient
Age 18 - 80 years

Exclusion Criteria

No informed consent
Infection in the past four weeks

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>1. The trained immunity profile of monocytes from renal transplant patients.<br /><br>Before, one week after, and three months after renal transplantation, blood is<br /><br>drawn from patients and circulating monocytes are isolated to examine the<br /><br>activity, transcriptome, and epigenome of these monocytes.<br /><br><br /><br>2. The association between trained immunity and renal transplant survival.<br /><br>The association between the trained immunity profile as measured in (1) and<br /><br>graft survival in the first two years after transplantation is investigated.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>1. The association between trained immunity and inflammation and tissue damage.<br /><br>The association between the trained immunity profile as measured in (1) and<br /><br>markers for tissue damage and systemic inflammation is investigated.<br /><br><br /><br>2. The association between trained immunity and the concentration of<br /><br>immunosuppressive drugs in the blood of patients.<br /><br><br /><br>3. The association between trained immunity and the amount of white blood cells<br /><br>and subsets of white blood cells.</p><br>
© Copyright 2025. All Rights Reserved by MedPath